Professional Documents
Culture Documents
1. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al.
Prevention of venous thromboembolism: the Seventh ACCP Conference on
Antithrombotic and Thrombolytic Therapy. Chest 2004 (Sep);126(3
Suppl):338S400S.
2. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson Jr FA, et
al. Prevention of venous thromboembolism. Chest 2001 (Jan);119(1
Suppl):132S75S.
3. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton III
LJ. Risk factors for deep vein thrombosis and pulmonary embolism: a
population-based case-control study. Arch Intern Med 2000 (Mar
27);160(6):80915.
4. Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R, et al.
Rates of initial and recurrent thromboembolic disease among patients with
malignancy versus those without malignancy. Risk analysis using Medicare
claims data. Medicine (Baltimore) 1999 (Sep);78(5):28591.
5. Silverstein MD, Heit JA, Mohr DN, et al: Trends in the incidence of deep
vein thrombosis and pulmonary embolism: A 25-year population-based study.
Arch Intern Med 158:585-593, 1998
6. Gallus AS: Prevention of post-operative deep leg vein thrombosis in patients
with cancer. Thromb Haemost 78:126-132, 1997
7. Einstein MH, Pritts EA, Hartenbach EM. Venous thromboembolism
prevention in gynecologic cancer surgery: A systematic review. Gynecol
Oncol 105 (2007) 813-819.
8. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton III
LJ. Predictors of survival after deep vein thrombosis and pulmonary
embolism: a population-based, cohort study. Arch Intern Med 1999
(Mar8);159(5):44553.
9. Morgan MA, Iyengar TD, Napiorkowski BE, Rubin SC, Mikuta JJ. The
clinical course of deep vein thrombosis in patients with gynecologic cancer.
Gynecol Oncol 2002 (Jan);84(1):6771.